Scholarlink

<p>Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022 (Ozaki et al. in Cardiovasc Interv Ther 33:178–203, 2018), (Ozaki et al. in Cardiovasc Interv Ther 37:1–34, 2022). Following the publication of the 2023 European Society of Cardiology (ESC) Guidelines for the management of acute coronary syndromes, the CVIT Task Force released another revised version in 2024 (Ozaki et al. in Cardiovasc Interv Ther 39:335–375, 2024). In light of new clinical evidence and technological advances that have emerged since then, the Task Force now proposes an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2026 version.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月26日

查看全文
  • Yukio Ozaki,
  • Akihiro Tobe,
  • Yoshinobu Onuma,
  • Kotaro Miyashita,
  • Yoshio Kobayashi,
  • Tetsuya Amano,
  • Kyohei Yamaji,
  • Hideki Ishii,
  • Takashi Muramatsu,
  • Tevfik F. Ismail,
  • Shun Kohsaka,
  • Yoshihisa Nakagawa,
  • Yoshihiro Morino,
  • Shiro Uemura,
  • Kenichi Tsujita,
  • Toshiro Shinke,
  • Junya Ako,
  • Junji Yajima,
  • Yuichiro Maekawa,
  • Junya Shite,
  • Yasumi Igarashi,
  • Nobuo Shiode,
  • Atsunori Okamura,
  • Takayuki Ogawa,
  • Junichi Yamaguchi,
  • Toshihiro Tamura,
  • Takafumi Tsuji,
  • Kentaro Hayashida,
  • Teruyasu Sugano,
  • Hiroyuki Okura,
  • Hideki Okayama,
  • Katsuhiro Kawaguchi,
  • Kan Zen,
  • Saeko Takahashi,
  • Kazuhiko Nakazato,
  • Nobuhiro Suematsu,
  • Kiyoshi Hironaga,
  • Tetsuya Matoba,
  • Osamu Iida,
  • Masaharu Ishihara,
  • Masaya Ohta,
  • Masahide Harada,
  • Reina Ozaki,
  • Hideo Izawa,
  • Toyoaki Murohara,
  • Takafumi Ueno,
  • Masato Nakamura,
  • Yuji Ikari,
  • Patrick W. Serruys,
  • Ken Kozuma

摘要

Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022 (Ozaki et al. in Cardiovasc Interv Ther 33:178–203, 2018), (Ozaki et al. in Cardiovasc Interv Ther 37:1–34, 2022). Following the publication of the 2023 European Society of Cardiology (ESC) Guidelines for the management of acute coronary syndromes, the CVIT Task Force released another revised version in 2024 (Ozaki et al. in Cardiovasc Interv Ther 39:335–375, 2024). In light of new clinical evidence and technological advances that have emerged since then, the Task Force now proposes an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2026 version.